Early-onset neonatal group B streptococcal infection: implications for practice

Area of Science:

• Neonatal infectious diseases
• Bacterial pathogenesis
• Public health interventions

Background:

• Group B Streptococcus (GBS) is a primary cause of neonatal morbidity and mortality in the US.
• Intrapartum antimicrobial prophylaxis can prevent most GBS neonatal infections in high-risk mothers.
• Current GBS prevention strategies lack consistent implementation, hindering a decline in neonatal GBS disease incidence.

Purpose of the Study:

• To underscore the importance of understanding GBS epidemiology and clinical presentation for neonatal care.
• To highlight the need for enhanced decision-making skills among PNPs regarding GBS prevention.
• To equip PNPs to evaluate and compare emerging GBS prevention strategies.

Main Methods:

• Review of GBS epidemiology and clinical presentation.
• Analysis of current intrapartum antimicrobial prophylaxis guidelines and their limitations.
• Evaluation of factors influencing the consistent implementation of prevention strategies.

Main Results:

• Despite available prevention methods, neonatal GBS disease incidence remains a significant concern.
• Inconsistent application of prophylaxis protocols contributes to the lack of decline in GBS infections.
• Enhanced understanding of GBS is crucial for effective clinical management.

Conclusions:

• Effective GBS prevention requires consistent application of evidence-based strategies.
• PNPs play a critical role in managing and preventing neonatal GBS infections.
• Further research and improved implementation are necessary to reduce the burden of neonatal GBS disease.